Bli medlem
Bli medlem

Du är här


Pihlajalinna Oyj: Change in Pihlajalinna Plc's Management Team

Pihlajalinna Plc Stock Exchange Release 1 February 2017 at
12.30 p.m.

Change in Pihlajalinna Plc's Management Team

Pihlajalinna Group's Senior Vice president, Primary and Social Care segment,
Virpi Holmqvist has resigned from her position in Pihlajalinna and will move
on to new duties outside the Group. Her employment ends on 1 August 2017 at
the latest.

"Our collaboration remains regrettably short. I wish Virpi Holmqvist the best
of luck with new challenges", says CEO Aarne Aktan.

The new segment director will be appointed as soon as possible.

Pihlajalinna Plc

For further information, please contact:

Aarne Aktan, CEO, +358 40 342 4440


Nasdaq Helsinki
Key media

Pihlajalinna in brief

Pihlajalinna is one of the leading private social and healthcare services
providers in Finland. The Company provides social and healthcare services for
households, companies, insurance companies and public sector entities in
private clinics, health centres, dental clinics and hospitals around Finland.
Pihlajalinna provides general practitioner and specialised care services,
including emergency and on-call services, a wide range of surgical services,
occupational healthcare and dental care services, in private clinics and
hospitals operating under the Dextra brand. Under the Pihlajalinna brand the
Company, in cooperation with the public sector, offers social and healthcare
service provision models to public sector entities with the aim of providing
high quality services for public pay healthcare customers.

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Pihlajalinna Oyj via Globenewswire

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.